1-4 of 4
Mark Uhlik
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB-A31: Imprime PGG (Imprime) plus pembrolizumab (PEM): a phase 2 immunotherapeutic combination in patients selected for an Imprime-specific biomarker

Steven O'Day, Nandita Bose, Mark Uhlik, Radha Prathikanti, Ben Harrison, Steven Leonardo, Richard Huhn, Nadine Ottoson, Xiaohong Qiu, Richard Walsh, Paulette Mattson, Mable Ma, Katie Ertelt, Jamie Lowe, Michele A. Gargano, Michael Chisamore, Bruno Osterwalder, Jeremy Graff
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): LB-A31.
DOI: https://doi.org/10.1158/1535-7163.TARG-17-LB-A31
Published: 01 January 2018
View article
Journal Articles

Abstract B009: Imprime PGG, a soluble yeast b-glucan PAMP, activates both innate and adaptive immune effector cells, resulting in enhanced antitumor responses that synergize with anti-PD-1 antibody therapy

Steven Leonardo, Ross B. Fulton, Kathryn A. Fraser, Takashi O. Kangas, Keith B. Gorden, Ben Harrison, Adria LB Jonas, Anissa SH Chan, Yumi Yokayama, Nandita Bose, Jeremy R. Graff, Mark Uhlik
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): B009.
DOI: https://doi.org/10.1158/1535-7163.TARG-17-B009
Published: 01 January 2018
View article
Journal Articles

Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis

Giulio Francia, Yuval Shaked, Kae Hashimoto, John Sun, Melissa Yin, Carolyn Cesta, Ping Xu, Shan Man, Christina Hackl, Julie Stewart, Mark Uhlik, Anne H. Dantzig, F. Stuart Foster, Robert S. Kerbel
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (3): 680–689.
DOI: https://doi.org/10.1158/1535-7163.MCT-11-0659
Published: 06 March 2012
View article
PDF
Includes: Multimedia, Supplementary data
Journal Articles

Tasisulam Sodium, an Antitumor Agent That Inhibits Mitotic Progression and Induces Vascular Normalization

Timothy Meier, Mark Uhlik, Sudhakar Chintharlapalli, Michele Dowless, Robert Van Horn, Julie Stewart, Wayne Blosser, James Cook, Debra Young, Xiang Ye, Glenn Evans, Kelly Credille, Darryl Ballard, Lysiane Huber, Andrew Capen, Marcio Chedid, Robert Ilaria, Jr, Michele C. Smith, Louis Stancato
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11): 2168–2178.
DOI: https://doi.org/10.1158/1535-7163.MCT-11-0323
Published: 08 November 2011
View article
PDF
Includes: Supplementary data